The core of the innovation lies in a structure known as V-type starch. Amylose, the linear component of starch, can wrap itself into a single left-handed helix with a hydrophobic inner cavity. This cavity readily accommodates small hydrophobic guests such as fatty acids, organic solvents, and aroma compounds, producing a characteristic V-type crystalline diffraction pattern. Such inclusion complexes have long attracted attention as low-cost, biodegradable vehicles for encapsulating and controlling the release of functional ingredients in foods. The trouble is that the most common way of making them, an ethanol-induced process that produces so-called V-type granular starch, yields structures that fall apart in aqueous environments, severely limiting their usefulness in drug encapsulation and sustained-release applications where water is unavoidable.

The research team hypothesized that electrostatics could solve this instability problem. Instead of starting with ethanol-treated starch, they began with native high-amylose maize starch, a material with an amylose content of roughly 61 percent, and chemically grafted quaternary ammonium groups onto its backbone. The modification used 2,3-epoxypropyl trimethylammonium chloride, or EPTAC, as an etherifying agent, reacting with the starch hydroxyl groups through nucleophilic substitution under alkaline conditions at 55 degrees Celsius. The researchers prepared a series of cationic starches using EPTAC concentrations ranging from 5 to 30 percent of the starch dry weight, alongside an unmodified control. Lauric acid, a twelve-carbon fatty acid that carries a negative charge in alkaline environments, was then dissolved in ethanol and added dropwise into the positively charged starch suspensions at 65 degrees Celsius, allowing the oppositely charged partners to find each other and assemble.

Confirming that the modification had worked required a battery of analytical techniques. Scanning electron microscopy showed that increasing etherifying agent concentrations progressively damaged the starch granules, with the structurally vulnerable hilum region collapsing at the highest dosage. Zeta potential measurements told the more important story: whereas the unmodified starch carried a negative surface potential of about minus 17.6 millivolts, even 5 percent EPTAC flipped the charge to plus 18.2 millivolts, and 30 percent EPTAC pushed it to plus 25.4 millivolts. Proton nuclear magnetic resonance spectroscopy revealed a new peak at 3.20 parts per million corresponding to the methyl protons of the grafted quaternary ammonium groups, and the calculated degree of substitution rose in a dose-dependent manner, reaching its maximum at the highest EPTAC level. Fourier-transform infrared spectroscopy showed characteristic shifts in the carbon-oxygen and carbon-hydrogen stretching vibrations, confirming that the electron density around the starch backbone had been altered by the cationic groups.

The X-ray diffraction results provided the most direct evidence that the electrostatic strategy was driving V-type complex formation. The unmodified starch mixed with lauric acid retained its native B-type crystalline pattern, with peaks near 17, 20, and 23 degrees two-theta, indicating that the negatively charged starch surface simply repelled the negatively charged fatty acid. Once even modest cationization was introduced, however, the B-type peaks nearly vanished and weak V-type peaks emerged at 12.86 and 19.79 degrees, signaling that leached amylose molecules had threaded lauric acid into their helical cavities. As the etherifying agent concentration climbed, the V-type crystallinity rose dramatically from 9.22 percent to 24.60 percent at the 30 percent dosage, demonstrating that surface charge density directly governs how efficiently the helical complexes assemble.

Thermal analyses reinforced this picture. Differential scanning calorimetry showed no meaningful endothermic peak for the unmodified starch-lauric acid mixture, confirming that negligible complexation occurred without positive charges. In contrast, the cationized samples developed clear melting transitions, and the enthalpy change reached 1.45 joules per gram at the highest EPTAC concentration, indicating the largest proportion of V-type structure among all samples. Thermogravimetric analysis added a further dimension: as the degree of substitution increased, the temperature of maximum weight loss shifted upward from 281.32 to 298.53 degrees Celsius, consistent with stronger electrostatic affinity producing more thermally stable complexes between amylose and the fatty acid.

Rheological measurements revealed how these molecular interactions translate into bulk material behavior. The cationic starch-lauric acid system formed a weak gel whose storage modulus exceeded its loss modulus across the entire tested frequency range, the classic signature of a cohesive gel network. The cationic starch alone, lacking the fatty acid partner, produced far weaker moduli, showing that hydrogen bonds and van der Waals forces between starch chains are insufficient to build a robust network. Most strikingly, when the researchers soaked the gel in sodium chloride solution, the electrostatic interactions were screened and the entire structure collapsed, with the moduli dropping to their lowest values and the material behaving like a simple Newtonian fluid. This salt-sensitivity experiment provided elegant proof that the gel’s integrity depends on electrostatic attraction rather than any other binding mechanism, and steady-shear tests showed the intact gel displaying characteristic shear-thinning pseudoplastic behavior with the highest apparent viscosity of all samples.

The payoff came in the in vitro digestion assays, which used pancreatic alpha-amylase and amyloglucosidase at 37 degrees Celsius to simulate small-intestinal conditions. The unmodified starch-lauric acid mixture proved highly digestible, with rapidly digestible starch accounting for 58.85 percent of the material and resistant starch only 22.81 percent. As cationization increased, the profile shifted steadily toward resistance: at 15 and 20 percent EPTAC, resistant starch content rose to 25.82 and 29.24 percent respectively while rapidly digestible starch fell to 49.30 and 44.74 percent. At the maximum dosage of 30 percent, resistant starch peaked at 31.80 percent. The mechanism is straightforward but powerful: the electrostatically driven complexes form compact, ordered networks that physically shield the starch from enzymatic access, while the V-type helices themselves are structures that digestive enzymes struggle to unwind.

Intriguingly, the relationship between charge and digestibility was not perfectly monotonic. Although the 30 percent sample achieved the highest V-type crystallinity, its resistant starch content was only marginally higher than the 20 percent sample, and the authors attribute this to excessive cationization making the starch network so hydrophilic that it swells massively in the digestion buffer, increasing matrix porosity and giving enzymes easier access to amorphous regions. This suggests an optimal window of moderate cationization where structural reinforcement and matrix compactness are balanced, a nuance that will matter for anyone attempting to translate the findings into real food formulations.

The study’s authors are candid about its limitations. EPTAC-modified cationic starch faces strict regulatory limits for food applications, and direct toxicity data for such materials remain limited, even though cationic starches are widely explored in drug delivery and tissue engineering thanks to their biodegradability and biocompatibility. The team proposes that future work should pursue natural, food-grade polycations such as chitosan to achieve similar electrostatically driven V-type complexation, followed by comprehensive in vivo safety and metabolic assessments. Even so, the demonstration that a simple charge-matching trick can stabilize V-type starches in water, boost their thermal robustness, and raise their resistant starch content by nearly nine percentage points represents a versatile new platform for designing starch-based ingredients. If the approach can be reproduced with food-safe polycations, the humble starch granule may soon become a far more sophisticated tool for controlled nutrition and ingredient delivery.

Subject of Research: Electrostatic construction of digestion-resistant V-type starch complexes from cationic starch and lauric acid

Article Title: Construction of electrostatic binding V -type starches using cationic starch and lauric acid: Insight into enhanced digestive resistance

Article References: Ding, Z., Li, W., Xu, C., Wang, Y., & Chen, X. (2026). Construction of electrostatic binding V-type starches using cationic starch and lauric acid: Insight into enhanced digestive resistance. Food Chemistry: X, Article 104597. https://doi.org/10.1016/j.fochx.2026.104597

Image Credits: AI Generated

DOI: 10.1016/j.fochx.2026.104597

Keywords: V-type starch, cationic starch, lauric acid, resistant starch, electrostatic interaction, amylose inclusion complex, starch digestibility, rheology, X-ray diffraction, food chemistry, encapsulation, high-amylose maize starch

Chitosan is produced by deacetylating chitin, the structural polymer that fortifies crustacean shells and fungal cell walls. What makes the molecule chemically interesting is its behavior at acidic pH: in that range, abundant amino groups along its backbone grab protons from solution, converting the neutral polymer into a polycation studded with positive charges. Yeast cells, by contrast, present a largely negative face to the world, with phosphorylated mannans, glucans, and other acidic components decorating their cell walls and membranes. Opposite charges attract, and that simple electrostatic logic underlies everything chitosan does to a fungal cell. When the polycation docks onto the negatively charged cell periphery, it disrupts the carefully regulated barrier function of the envelope, allowing small molecules to leak in and out and, at sufficient concentrations, halting growth altogether.

Exactly how this interaction plays out, however, varies dramatically from one fungal species to another, and that variability is where the new study makes its mark. The Mexican team compared three yeasts with very different lifestyles and clinical relevance: Saccharomyces cerevisiae, the brewer’s and baker’s yeast that serves as the workhorse of eukaryotic cell biology; Candida albicans, a common human commensal and opportunistic pathogen; and Debaryomyces hansenii, a salt-tolerant yeast famous for colonizing cheese rinds and other extreme food environments. By tracking growth in the presence of chitosan across these species, the researchers established a clear hierarchy of susceptibility. Debaryomyces hansenii emerged as the most vulnerable of the three, its growth strongly inhibited by the polymer, while the other species displayed comparatively milder responses. The result underscores a point that has been emerging from the antifungal literature for years: chitosan is not a blunt instrument but a strain-dependent agent whose potency depends on the fine chemistry of each organism’s surface.

To find out why, the team needed to watch chitosan in action rather than merely tally its consequences. They turned to a fluorescent version of the molecule, conjugating chitosan to fluorescein isothiocyanate, a dye that glows green under the microscope. This allowed them to monitor where the polymer goes and how firmly it sticks. The binding assays showed that chitosan associates with the cell periphery of all three species, becoming incorporated at the cell surface over time, but the extent of that association tracked with each species’ sensitivity. The cells that bound the polymer most avidly and internalized it most readily were the ones whose growth suffered most. In other words, the antifungal effect is not some diffuse, indirect consequence of chitosan’s presence in the medium; it is written in the physical contact between polymer and cell.

Transmission electron microscopy provided the structural confirmation. Ultrastructural examination of treated cells revealed the damage that chitosan inflicts on the yeast envelope, consistent with its role as a permeabilizing agent. Where the polymer had acted, the orderly architecture of the cell wall and plasma membrane was compromised, and the cells showed the kinds of lesions expected when a barrier designed to hold contents in and keep the environment out begins to fail. Together, the fluorescence binding data and the electron micrographs built a coherent mechanistic picture: chitosan’s positive charges latch onto negatively charged cell-surface components, the interaction destabilizes the envelope, and permeability rises as a direct result.

What elevates the study beyond a mechanistic curiosity is the application the researchers built on top of it. If chitosan can open yeast cells in a controlled, tunable way, then those permeabilized cells become analytical tools in their own right. The team demonstrated exactly that, using chitosan-induced permeabilization to measure the activity of selected enzymes in situ, meaning inside cells that remain structurally intact rather than in messy homogenates. In situ measurements of this kind have long been a goal in enzymology because they preserve the native context of the cell: substrates and cofactors diffuse in through the permeabilized envelope, reactions proceed within the crowded, compartmentalized interior, and the activities read out reflect the enzymes as they actually exist in the organism, not as they behave after extraction and purification.

The practical implications ripple outward in several directions. For basic researchers probing fungal physiology, permeabilized yeast offers a faster and arguably more faithful route to enzyme kinetics than classical cell-free assays, which require breaking cells open, clarifying lysates, and accepting that much of the native organization is lost along the way. For the biotechnology sector, where yeasts are engineered to produce everything from bioethanol to pharmaceutical proteins, a simple chemical treatment that exposes intracellular biochemistry without destroying the cells could accelerate screening and process monitoring. And for those studying antifungal action itself, the species-dependent results provide a comparative framework: understanding why Debaryomyces hansenii is exquisitely sensitive while its relatives are more resistant may point toward the surface features, wall composition, or membrane properties that determine chitosan susceptibility in fungi more broadly.

The work also carries a certain elegant irony. Chitosan has been marketed for decades as a weight-loss supplement and wound dressing, and its antimicrobial properties have been exploited in food packaging and agriculture, yet the molecular details of its interaction with fungal cells have remained only partially resolved. By combining growth analysis, fluorescent binding assays, electron microscopy, and functional biochemistry in a single coherent experimental program, the UNAM team has connected those dots across three yeast species, showing that a single electrostatic mechanism, tuned by each species’ surface chemistry, explains both the antifungal effect and the analytical utility of the molecule. The same property that makes chitosan lethal at high doses makes it a precise instrument at controlled ones.

There are, of course, caveats and open questions. The study examined three species, and the authors themselves frame chitosan’s effects as strain-dependent, which means extrapolation to other fungi, particularly filamentous molds or clinically resistant Candida strains, will require further comparative work. The precise molecular targets of chitosan at the cell periphery, and the structural thresholds that separate reversible permeabilization from irreversible damage, remain fertile ground for future investigation. The researchers also note that their article was shared early as a citable, peer-reviewed accepted version subject to further editorial processing, so some details may be refined in the final version of record.

Even so, the central achievement stands. A team working with modest resources, supported by grants from UNAM’s Dirección General de Asuntos del Personal Académico, has taken a molecule familiar from seafood waste streams and turned it into a dual-purpose reagent: an antifungal agent whose species-specific action illuminates the chemistry of the fungal envelope, and a permeabilization tool that lets enzymologists watch metabolism from the inside. As interest in fungal biology grows, driven by rising rates of invasive fungal infections and by the central role of yeasts in industrial fermentation, tools that bridge the gap between living cells and laboratory measurement are likely to be in steady demand. Chitosan, it turns out, was sitting on the shelf all along.

Subject of Research: Chitosan-induced permeabilization of yeast cell envelopes and its application to in situ enzymatic measurements

Article Title: Chitosan-induced permeabilization in yeast and its use for in situ enzymatic measurements

Article References: Araiza-Villanueva, M., Sánchez, N. S., Calahorra, M., Padilla-Garfias, F., & Peña, A. (2026). Chitosan-induced permeabilization in yeast and its use for in situ enzymatic measurements. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-026-14027-1

Image Credits: AI Generated

DOI: 10.1007/s00253-026-14027-1

Keywords: chitosan, yeast, cell permeabilization, Saccharomyces cerevisiae, Candida albicans, Debaryomyces hansenii, in situ enzyme activity, electrostatic interaction, antifungal agents, fungal physiology, transmission electron microscopy, fluorescein isothiocyanate